Pharma & Biopharma

Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery

Sitting Down With… Koen Sandra, CEO and Co-owner, RIC group; Visiting Professor, Ghent University, Belgium

The latest chromatography research – from moth aphrodisiacs to vaccine biomanufacturing

A roundup of this month’s business news – from partnerships to product launches, including a new in-line spectrometer for bioprocess control

Has the current era of biomedical mass spec crossed the finish line? Naysayers be warned: we’ve been here before…

Nitrosamines are carcinogenic at low concentrations, able to form in medicines over time, and difficult to detect using conventional techniques…

Polymeric drug delivery systems have enormous potential for personalized medicine, but their complexity create real characterization challenges

Are ultra-short chromatography columns fit for pharma?

After receiving the Uwe Neue Award, Tom Walter discusses his career in chromatography at Waters

Discussing the multidisciplinary engineering challenge that is developing increasingly small mass spectrometry instruments with Kevin J. Knopp